Larson Financial Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Larson Financial Group's AMLX Position: Q3 2026 in Review
Larson Financial Group increased its Amylyx Pharmaceuticals (AMLX) stake by 103% in Q3 2026, buying an estimated $3.87K and bringing the position to 288 shares worth $8.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2595.
Larson Financial Group first reported a position in AMLX in Q4 2025 and has held it in 4 quarters since. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Larson Financial Group held 288 shares of Amylyx Pharmaceuticals worth $8.38K as of Q3 2026.
- Larson Financial Group bought 146 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $3.87K.
- Amylyx Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2595 holding.
- Larson Financial Group first reported a position in Amylyx Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.